Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Other Accumulated Expenses (2021 - 2025)

Historic Other Accumulated Expenses for Abeona Therapeutics (ABEO) over the last 5 years, with Q3 2025 value amounting to $35000.0.

  • Abeona Therapeutics' Other Accumulated Expenses rose 340000.0% to $35000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $35000.0, marking a year-over-year increase of 340000.0%. This contributed to the annual value of $64000.0 for FY2024, which is 630000.0% up from last year.
  • Latest data reveals that Abeona Therapeutics reported Other Accumulated Expenses of $35000.0 as of Q3 2025, which was up 340000.0% from $80000.0 recorded in Q2 2025.
  • Abeona Therapeutics' Other Accumulated Expenses' 5-year high stood at $317000.0 during Q1 2025, with a 5-year trough of $1000.0 in Q4 2023.
  • In the last 5 years, Abeona Therapeutics' Other Accumulated Expenses had a median value of $80000.0 in 2025 and averaged $123769.2.
  • As far as peak fluctuations go, Abeona Therapeutics' Other Accumulated Expenses tumbled by 9951.22% in 2024, and later skyrocketed by 3160000.0% in 2025.
  • Quarter analysis of 5 years shows Abeona Therapeutics' Other Accumulated Expenses stood at $296000.0 in 2021, then crashed by 31.08% to $204000.0 in 2022, then plummeted by 99.51% to $1000.0 in 2023, then soared by 6300.0% to $64000.0 in 2024, then plummeted by 45.31% to $35000.0 in 2025.
  • Its last three reported values are $35000.0 in Q3 2025, $80000.0 for Q2 2025, and $317000.0 during Q1 2025.